NDAORALSOLUTION
Approved
Oct 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 14h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOLTAMOX (tamoxifen citrate) is an oral solution formulation of tamoxifen, a selective estrogen receptor modulator (SERM) used primarily in breast cancer treatment and prevention. The drug works by blocking estrogen receptors on breast cancer cells, inhibiting their growth and proliferation. It is indicated for patients with hormone receptor-positive breast cancer across multiple treatment settings.
$0.469MPart D
LOE ApproachingMinimal commercial activity with only $469K in Part D spending suggests a niche or declining franchise; limited team expansion expected.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Started Sep 2010
84 enrolled
Breast Cancer
Career Relevance
Working on SOLTAMOX offers limited career growth opportunity given minimal commercial footprint (0 linked jobs, $469K spending) and approaching loss of exclusivity. Career development would be constrained to maintenance roles with little innovation exposure; professionals should consider this a stabilization or transition assignment rather than a growth platform.
Brand Manager
Worked on SOLTAMOX at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.